Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

Summary

The purpose of this study is to determine if ticagrelor is as effective as clopidogrel in rate of onset and degree of platelet inhibition for patients with non-ST elevation of acute coronary syndrome (NSTE-ACS) undergoing ad hoc percutaneous coronary intervention (PCI) with bivalirudin.

Timeline

Start

2014-09

Primary completion

2015-04

Completion

2015-04

Outcome

Outcome not reported

Stopped (Enrollment): “Patient recruitment challenges, low enrolment, and a forecasted inability to complete the study in an acceptable timeframe”

Drugs

Indications